Most recent update: Thursday, February 14, 2019 - 14:58

Bariatric News - Cookies & privacy policy

You are here

%2 News

13/02/19 - Event
Meeting preview
On behalf of the executive council of the IFSO Middle East North Africa Chapter (MENAC) it is my honor, privilege and great pleasure to invite you to the 1st IFSO MENAC congress to be held in Kuwait-...
12/02/19 - Industry
Product launch
Novo Nordisk UK has announced that Ozempic (semaglutide), a once-weekly GLP-1 analogue injection1 for the treatment of type 2 diabetes is now available in the UK. According to the company, Ozempic...
13/02/19 - Research
Mesenteric defect closures
Closure of the mesenteric defects using either non-absorbable metal clips or non-absorbable running sutures is a safe and effective measure to reduce the risk for small bowel obstruction after...
12/02/19 - Research
Obesity and cancer
A sharp increase in obesity-linked cancers among young adults in the US could foreshadow a reversal in the overall decline in cancer mortality. In a sweeping study covering two-thirds of the US...
12/02/19 - Research
Surgery and T2DM
Three quarters of individuals with type 2 diabetes (T2D) who have Roux-en-Y gastric bypass surgery (RYGB) experienced diabetes remission within one year of treatment, according to researchers from...
14/02/19 - Research
Patient experiences
A PhD student at Swansea University has begun a study that is exploring patient experiences during their journey through bariatric surgery. Specifically, looking at the patients’ responses to...
14/02/19 - Research
EndoBarrier Pivotal Trial
GI Dynamics has received Institutional Review Board (IRB) approval to conduct its pivotal trial of EndoBarrier for type 2 diabetes and obesity. The pivotal trial of EndoBarrier, referred to as the 18...
13/02/19 - Research
Oestrogen and T2DM
The results of a Texas A&M University-led study provide insights into the mechanism by which oestrogen can decrease insulin resistance and the production of glucose, reducing incidences of Type 2...

Monthly archive